Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection

J Hypertens. 2005 Jun;23(6):1273-5. doi: 10.1097/01.hjh.0000170394.99697.b3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bartter Syndrome / drug therapy*
  • Bartter Syndrome / metabolism
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Hypertension / metabolism
  • Hypertension / prevention & control*
  • Hypokalemia / drug therapy*
  • Hypokalemia / metabolism
  • Intracellular Signaling Peptides and Proteins
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • rho-Associated Kinases

Substances

  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases